BE899059A - Derives de benzamide - Google Patents

Derives de benzamide

Info

Publication number
BE899059A
BE899059A BE0/212488A BE212488A BE899059A BE 899059 A BE899059 A BE 899059A BE 0/212488 A BE0/212488 A BE 0/212488A BE 212488 A BE212488 A BE 212488A BE 899059 A BE899059 A BE 899059A
Authority
BE
Belgium
Prior art keywords
compounds
dichloro
benzamide derivatives
new
methylenedioxy
Prior art date
Application number
BE0/212488A
Other languages
English (en)
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE899059A publication Critical patent/BE899059A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/212488A 1983-03-03 1984-03-02 Derives de benzamide BE899059A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.

Publications (1)

Publication Number Publication Date
BE899059A true BE899059A (fr) 1984-09-03

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212488A BE899059A (fr) 1983-03-03 1984-03-02 Derives de benzamide

Country Status (28)

Country Link
JP (1) JPS59167552A (enrdf_load_stackoverflow)
KR (1) KR910008202B1 (enrdf_load_stackoverflow)
AR (1) AR243155A1 (enrdf_load_stackoverflow)
AT (1) AT390948B (enrdf_load_stackoverflow)
AU (2) AU570431B2 (enrdf_load_stackoverflow)
BE (1) BE899059A (enrdf_load_stackoverflow)
CA (1) CA1252794A (enrdf_load_stackoverflow)
CH (1) CH653670A5 (enrdf_load_stackoverflow)
DE (1) DE3407654C2 (enrdf_load_stackoverflow)
DK (1) DK166382C (enrdf_load_stackoverflow)
ES (3) ES530230A0 (enrdf_load_stackoverflow)
FI (1) FI79297C (enrdf_load_stackoverflow)
FR (1) FR2541996B1 (enrdf_load_stackoverflow)
GB (1) GB2135998B (enrdf_load_stackoverflow)
GR (1) GR81866B (enrdf_load_stackoverflow)
HU (1) HU193556B (enrdf_load_stackoverflow)
IE (1) IE57004B1 (enrdf_load_stackoverflow)
IL (1) IL71078A (enrdf_load_stackoverflow)
IT (1) IT1173365B (enrdf_load_stackoverflow)
LU (1) LU85231A1 (enrdf_load_stackoverflow)
MC (1) MC1568A1 (enrdf_load_stackoverflow)
NL (1) NL8400459A (enrdf_load_stackoverflow)
NO (1) NO165999C (enrdf_load_stackoverflow)
NZ (1) NZ207272A (enrdf_load_stackoverflow)
PH (1) PH19623A (enrdf_load_stackoverflow)
PT (1) PT78187B (enrdf_load_stackoverflow)
SE (1) SE466447B (enrdf_load_stackoverflow)
ZA (1) ZA841394B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (enrdf_load_stackoverflow) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
KR910008202B1 (ko) 1991-10-11
AT390948B (de) 1990-07-25
DE3407654C2 (de) 1994-04-07
AU8307987A (en) 1988-06-16
IL71078A (en) 1987-12-31
SE8401190D0 (sv) 1984-03-02
GB2135998B (en) 1986-09-24
ZA841394B (en) 1985-06-26
IE57004B1 (en) 1992-03-11
ES8504680A1 (es) 1985-05-01
AU609758B2 (en) 1991-05-09
AR243155A1 (es) 1993-07-30
JPS59167552A (ja) 1984-09-21
SE466447B (sv) 1992-02-17
IL71078A0 (en) 1984-05-31
PT78187B (en) 1986-08-05
ES8506600A1 (es) 1985-08-16
JPH0430389B2 (enrdf_load_stackoverflow) 1992-05-21
FR2541996B1 (fr) 1987-12-11
DE3407654A1 (de) 1984-09-06
DK147584A (da) 1984-09-04
AU2506684A (en) 1984-09-06
DK166382B (da) 1993-05-10
ES8506601A1 (es) 1985-08-16
IT8419778A0 (it) 1984-02-23
PT78187A (en) 1984-04-01
FI79297C (fi) 1989-12-11
ES537046A0 (es) 1985-08-16
NO165999B (no) 1991-02-04
ES537045A0 (es) 1985-08-16
NZ207272A (en) 1987-07-31
FI840734L (fi) 1984-09-04
CA1252794A (en) 1989-04-18
DK166382C (da) 1993-09-27
GB2135998A (en) 1984-09-12
FI840734A0 (fi) 1984-02-22
HU193556B (en) 1987-10-28
NL8400459A (nl) 1984-10-01
FR2541996A1 (fr) 1984-09-07
GB8405486D0 (en) 1984-04-04
DK147584D0 (da) 1984-02-29
FI79297B (fi) 1989-08-31
GR81866B (enrdf_load_stackoverflow) 1984-12-12
MC1568A1 (fr) 1985-02-04
NO165999C (no) 1991-05-15
IT1173365B (it) 1987-06-24
IE840512L (en) 1984-09-03
CH653670A5 (de) 1986-01-15
ATA72484A (de) 1990-01-15
ES530230A0 (es) 1985-05-01
LU85231A1 (de) 1985-09-12
AU570431B2 (en) 1988-03-17
SE8401190L (sv) 1984-09-04
NO840797L (no) 1984-09-04
PH19623A (enrdf_load_stackoverflow) 1986-06-04
KR840009077A (ko) 1984-12-24

Similar Documents

Publication Publication Date Title
BE903334A (fr) Nouveaux derives naphtaleniques a action retinoique, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
GEP19960313B (en) Method for Production of Pyridin Derivatives
MX9202630A (es) Derivados de sulfamato anticonvulsivos.
CA2164638A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AU4546685A (en) Pyrazole analogs of mevalonolactone and derivatives thereof, process for their production and their use
GEP19960656B (en) Method for production of phenylalkylamines or its pharmaceutically acceptable salts
BR9307387A (pt) Agentes terapêuticos
ES2155093T3 (es) Nuevos inhibidores de la uridina fosforilasa (urdpasa) y de la dihidrouracil deshidrogenasa (dhudasa).
KR960000861A (ko) 퍼플루오로알킬 그룹을 갖는 페닐-치환된 알케닐카보구아니디드, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
FR2426694A1 (fr) Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique
PT83992B (pt) Processo para a preparacao de tio-eteres assimetricos
BE899059A (fr) Derives de benzamide
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
PT82032B (pt) Processo para a preparacao de derivados de aminoacidos com accao anticonvulsiva e de composicoes farmaceuticas que os contem
DK562488D0 (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
KR910019964A (ko) 하이드라존
IE42218L (en) Pyrazinoisoquinoline derivatives
Lippmann et al. Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog
BE905601A (fr) Derives de dichloroaniline.
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
BE1003067A5 (fr) Derives de la pyrimidine.
EA200400470A1 (ru) Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
LU83713A1 (fr) Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant
US4415591A (en) Use of aminoalkyl phenyl sulfide derivatives for the treatment of hypertension
BE899465A (fr) Composes d'ammonium quaternaire bactericides.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE A.G.

Effective date: 19950331